Drug Development Consulting BidCo ApS: Financial statements 2023
CVR: 42287067
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Drug Development Consulting BidCo ApS (CVR 42287067) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,320,000 and a net result of DKK -9,381,000 compared with DKK -11,831,000 the year before. That is a decrease of 38.3% compared with the year before. Equity in the 2023 report amounted to DKK 70,212,000. The solvency ratio was 58.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,320,000
- Profit/Loss
- DKK -9,381,000
- Equity
- DKK 70,212,000
- Total Assets
- DKK 120,669,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.3M | -9.4M | 70.2M | 1 |
| 2022 | - | 3.8M | -11.8M | 71.8M | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Drug Development Consulting BidCo ApS has published its annual report for 2022. Gross profit came to DKK 3,760,000, and the net result was DKK -11,831,000.
As of June 1, 2023, René Holmen Pedersen is registered as director of Drug Development Consulting BidCo ApS.
As of May 1, 2023, Rasmus Koch Nelund is registered as director of Drug Development Consulting BidCo ApS.
As of April 30, 2023, Alejandra Maria Cristina Bonifacini Mørk has stepped down as director of Drug Development Consulting BidCo ApS.
As of March 16, 2023, Niels Peder Nielsen has joined the board of directors of Drug Development Consulting BidCo ApS.
As of March 16, 2023, Alejandra Maria Cristina Bonifacini Mørk has joined the board of directors of Drug Development Consulting BidCo ApS.
As of March 16, 2023, Rafael Natanek has joined the board of directors of Drug Development Consulting BidCo ApS.
As of March 15, 2023, Rafael Natanek has left the board of directors of Drug Development Consulting BidCo ApS.
About Drug Development Consulting BidCo ApS
Drug Development Consulting BidCo ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of René Holmen Pedersen. The board consists of Niels Peder Nielsen (chair), Alejandra Maria Cristina Bonifacini Mørk, Rafael Natanek and Redmar Koene. The company is owned by Drug Development Consulting Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 5,875,000 and a net result of DKK -61,325,000 compared with DKK -13,215,000 the year before. Equity in the 2025 report amounted to DKK 32,493,000.
